Cargando…
Pulmonary hypertension in congenital heart disease
Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136120/ https://www.ncbi.nlm.nih.gov/pubmed/29792339 http://dx.doi.org/10.2217/fca-2017-0065 |
_version_ | 1783354939857174528 |
---|---|
author | Pascall, Emma Tulloh, Robert MR |
author_facet | Pascall, Emma Tulloh, Robert MR |
author_sort | Pascall, Emma |
collection | PubMed |
description | Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence between 5 and 10%. A multifactorial cause is recognized, relating to the size and nature of cardiac defect as well as environmental and genetic factors. More complex disease is increasingly recognized rather than pure Eisenmenger complex. Remodeling of the pulmonary vascular bed causes increased pulmonary vascular resistance diagnosed by a collection of investigations including echocardiography, exercise testing, cardiac catheterization, MRI and CT scanning. Management employs disease-modifying medications which are now used with increasing benefit. |
format | Online Article Text |
id | pubmed-6136120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61361202018-09-21 Pulmonary hypertension in congenital heart disease Pascall, Emma Tulloh, Robert MR Future Cardiol Review Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence between 5 and 10%. A multifactorial cause is recognized, relating to the size and nature of cardiac defect as well as environmental and genetic factors. More complex disease is increasingly recognized rather than pure Eisenmenger complex. Remodeling of the pulmonary vascular bed causes increased pulmonary vascular resistance diagnosed by a collection of investigations including echocardiography, exercise testing, cardiac catheterization, MRI and CT scanning. Management employs disease-modifying medications which are now used with increasing benefit. Future Medicine Ltd 2018-07 2018-05-24 /pmc/articles/PMC6136120/ /pubmed/29792339 http://dx.doi.org/10.2217/fca-2017-0065 Text en © 2018 Professor Robert Tulloh This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Review Pascall, Emma Tulloh, Robert MR Pulmonary hypertension in congenital heart disease |
title | Pulmonary hypertension in congenital heart disease |
title_full | Pulmonary hypertension in congenital heart disease |
title_fullStr | Pulmonary hypertension in congenital heart disease |
title_full_unstemmed | Pulmonary hypertension in congenital heart disease |
title_short | Pulmonary hypertension in congenital heart disease |
title_sort | pulmonary hypertension in congenital heart disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136120/ https://www.ncbi.nlm.nih.gov/pubmed/29792339 http://dx.doi.org/10.2217/fca-2017-0065 |
work_keys_str_mv | AT pascallemma pulmonaryhypertensionincongenitalheartdisease AT tullohrobertmr pulmonaryhypertensionincongenitalheartdisease |